TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/24 19:39 | 4/1/24 | BEAM | Beam Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Burrell Terry-Ann | MA | O | CFO | S | -175 | 32.12 | 0 | -5 | -7 | 70 | D | ||||||||||||||
7/14/23 18:52 | 7/12/23 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Burrell Terry-Ann | UT | D | S.m | -1,412 | 12.07 | 0 | -117 | -68 | 55 | D | |||||||||||||||
4/5/23 20:30 | 4/3/23 | BEAM | Beam Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Burrell Terry-Ann | MA | O | CFO | S.m | -138 | 29.74 | 0 | -5 | -9 | 47 | D | ||||||||||||||
1/30/23 16:05 | 1/26/23 | BEAM | Beam Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Burrell Terry-Ann | MA | O | CFO | S.dm | -1,680 | 45.08 | 0 | -37 | -54 | 31 | D | ||||||||||||||
1/25/23 17:25 | 1/23/23 | BEAM | Beam Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Burrell Terry-Ann | MA | O | CFO | S.dm | -911 | 45.02 | 0 | -20 | -39 | 31 | D | ||||||||||||||
1/20/23 16:18 | 1/18/23 | BEAM | Beam Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Burrell Terry-Ann | MA | O | CFO | S.d | -2,130 | 45.14 | 0 | -47 | -60 | 31 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |